Variant report
Variant | nsv1015384 |
---|---|
Chromosome Location | chr7:15144078-15163010 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000111846 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs539065957 | chr7:15144100-15144101 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs74605809 | chr7:15144112-15144113 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs148836578 | chr7:15144128-15144129 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs535162527 | chr7:15144152-15144153 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538147478 | chr7:15144165-15144166 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183929060 | chr7:15144178-15144179 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369590511 | chr7:15144182-15144183 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs374874742 | chr7:15144212-15144213 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs568472640 | chr7:15144216-15144217 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs188872818 | chr7:15144221-15144222 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs553450718 | chr7:15144224-15144225 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs537025656 | chr7:15144245-15144246 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs545464784 | chr7:15144252-15144253 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs193283340 | chr7:15144270-15144271 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs79012647 | chr7:15144296-15144297 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs141858788 | chr7:15144313-15144314 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544889075 | chr7:15144466-15144467 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs561417982 | chr7:15144514-15144515 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs530355850 | chr7:15144591-15144592 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs150187649 | chr7:15144596-15144597 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs370364286 | chr7:15144599-15144600 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs76658158 | chr7:15144606-15144607 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs376120153 | chr7:15144609-15144610 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs532672409 | chr7:15144641-15144642 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs17327498 | chr7:15144710-15144711 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs73063268 | chr7:15144757-15144758 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs138827499 | chr7:15144771-15144772 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374571851 | chr7:15144781-15144782 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188447394 | chr7:15144842-15144843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568250638 | chr7:15144909-15144910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs368690075 | chr7:15144924-15144925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs553705621 | chr7:15144967-15144968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570277958 | chr7:15144989-15144990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs371830797 | chr7:15144991-15144992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs191775684 | chr7:15144994-15144995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs112554776 | chr7:15145021-15145022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73063269 | chr7:15145022-15145023 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs568816777 | chr7:15145026-15145027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs184189855 | chr7:15145032-15145033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs188911723 | chr7:15145046-15145047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs540888476 | chr7:15145051-15145052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs114095437 | chr7:15145094-15145095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs532706699 | chr7:15145120-15145121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs546366327 | chr7:15145121-15145122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs562961754 | chr7:15145128-15145129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs147513453 | chr7:15145132-15145133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs548266498 | chr7:15145141-15145142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs568412919 | chr7:15145157-15145158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs541154196 | chr7:15145167-15145168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs527606397 | chr7:15145204-15145205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:15137000-15144800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
2 | chr7:15143800-15144200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr7:15143800-15146400 | Enhancers | Fetal Lung | lung |
4 | chr7:15144000-15144800 | Enhancers | Colon Smooth Muscle | Colon |
5 | chr7:15144400-15144800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr7:15144800-15145400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
7 | chr7:15159200-15160000 | Enhancers | Placenta Amnion | Placenta Amnion |
8 | chr7:15160000-15164000 | Weak transcription | Placenta Amnion | Placenta Amnion |
9 | chr7:15162400-15163800 | Enhancers | Muscle Satellite Cultured Cells | -- |
10 | chr7:15162800-15163800 | Enhancers | HUVEC | blood vessel |
11 | chr7:15163000-15163400 | Enhancers | Fetal Heart | heart |